[Federal Register Volume 66, Number 245 (Thursday, December 20, 2001)]
[Notices]
[Page 65744]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-31282]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 20, 2001, and published in the Federal 
Register on August 28, 2001, (66 FR 45340), Cedarburg Pharmaceuticals 
LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of tetrahydrocannabinols (7370), a basic class of 
controlled substance listed in Schedule I.
    The firm will manufacture tetrahydrocannabinols for another firm.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Cedarburg Pharmaceuticals, LLC to 
manufacture tetrahydrocannabinols is consistent with the public 
interest at this time. DEA has investigated the company to ensure that 
the company's registration is consistent with the public interest. 
These investigations have included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: November 20, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-31282 Filed 12-19-01; 8:45 am]
BILLING CODE 4410-09-M